Left atrial appendage occlusion addresses the tremendous unmet needs of stroke prevention in atrial fibrillation that persist despite recent advances in anticoagulation therapy

Circulation. 2014 Oct 21;130(17):1516-23. doi: 10.1161/CIRCULATIONAHA.114.008140.

Authors

Brian Whisenant¹, Saibal Kar², T Jared Bunch²

Affiliations

¹ From the Intermountain Medical Center, Salt Lake City, UT (B.W., T.J.B.); and Cedars Sinai Medical Center, Los Angeles, CA (S.K.). brian.whisenant@imail.org.
² From the Intermountain Medical Center, Salt Lake City, UT (B.W., T.J.B.); and Cedars Sinai Medical Center, Los Angeles, CA (S.K.).

PMID: 25332279
DOI: 10.1161/CIRCULATIONAHA.114.008140

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anticoagulants / therapeutic use*
Atrial Appendage / surgery*
Atrial Fibrillation*
Humans
Septal Occluder Device*
Stroke / etiology*

Substances

Anticoagulants